Neuronetics, Inc.
Income Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $41.6M | $34.5M | $41.8M | $37.3M | $38.1M | $32.0M | $22.5M | $18.5M |
| Cost of Revenue | $20.3M | $18.3M | $20.1M | $20.2M | $20.4M | $16.2M | $7.6M | $4.5M |
| Gross Profit | $21.2M | $16.2M | $21.7M | $17.1M | $17.8M | $15.7M | $14.9M | $14.0M |
| Gross Margin | 51.1% | 46.9% | 52.0% | 45.9% | 46.6% | 49.2% | 66.2% | 75.6% |
| Operating Expenses | ||||||||
| Research & Development | $1.3M | $1.4M | $1.7M | $1.5M | $1.8M | $1.6M | $5.8M | $2.4M |
| SG&A Expense | $11.4M | $13.0M | $13.3M | $11.1M | $12.2M | $13.1M | $10.8M | $7.4M |
| Operating Income | $-1.5M | $-9.0M | $-5.0M | $-7.3M | $-8.1M | $-11.0M | $-11.5M | $-7.7M |
| Operating Margin | -3.6% | -26.1% | -12.1% | -19.6% | -21.1% | -34.4% | -51.0% | -41.7% |
| Interest Expense | $2.1M | $2.3M | $1.5M | $2.2M | $2.0M | $1.9M | $1.8M | $1.7M |
| Pretax Income | — | — | — | — | — | — | — | — |
| Income Tax Expense | — | — | — | — | — | — | — | — |
| Net Income | $-3.4M | $-10.8M | $-7.2M | $-9.0M | $-10.1M | $-12.7M | $-12.7M | $-13.3M |
| Net Margin | -8.3% | -31.3% | -17.1% | -24.3% | -26.6% | -39.6% | -56.3% | -72.0% |
| EPS (Basic) | $-0.05 | $-0.16 | $-0.10 | $-0.07 | $-0.08 | $-0.11 | $-0.17 | $-0.22 |
| EPS (Diluted) | $-0.05 | $-0.16 | $-0.10 | $-0.07 | $-0.08 | $-0.11 | $-0.17 | $-0.22 |
| Shares Outstanding (Basic) | 73.1M | 69.6M | 66.0M | 134.6M | 132.4M | 122.9M | 63.5M | 60.5M |
| Shares Outstanding (Diluted) | 73.1M | 69.6M | 66.0M | 134.6M | 132.4M | 122.9M | 63.5M | 60.5M |
| Dividends Per Share | — | — | — | — | — | — | — | — |